Newly Approved Drug Therapies (566): Xenical/Orlistat Capsules, Roche

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Xenical/Orlistat Capsules

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Roche
Approval Status: Approved April 1999
Treatment for: Endocrinology

General Information

Xenical/Orlistat Capsules, 120 mg, a lipase inhibitor, have been approved for obesity management. Xenical acts by inhibiting the absorption of dietary fats.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]